Spero Therapeutics Inc. (SPRO)
0.77
-0.09 (-10.48%)
At close: Mar 28, 2025, 3:58 PM
0.79
3.61%
After-hours: Mar 28, 2025, 06:46 PM EDT
Spero Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Cash & Equivalents | 52.89M | 76.33M | 109.11M | 112.58M | 85.21M | 29.73M | 34.08M | 87.29M | 10.31M | 5.69M |
| Short-Term Investments | n/a | n/a | n/a | 33.82M | 41.7M | 52.31M | 81.36M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 21K | 233K | 50K | 50K | 50K |
| Other Long-Term Assets | 153K | 47.02M | 10.2M | 5.64M | 17.76M | 16.89M | 10.44M | 4.98M | 350K | 189K |
| Receivables | 52.48M | 50.7M | 1.08M | 2.64M | 6.18M | 8.55M | 1.3M | 2.94M | 304K | 10K |
| Inventory | n/a | n/a | -4.46M | n/a | -12.24M | -13.37M | -8.78M | -4.77M | n/a | n/a |
| Other Current Assets | 1.91M | 4.18M | 3.38M | 17.66M | 12.13M | 4.82M | 14.96M | 3.66M | 1.25M | 287K |
| Total Current Assets | 107.28M | 131.21M | 109.11M | 157.87M | 126.91M | 82.05M | 115.44M | 87.29M | 11.87M | 5.99M |
| Property-Plant & Equipment | 3.11M | 4.16M | 5.49M | 7.56M | 8.78M | 7.15M | 2.89M | 1.16M | 1.5M | 949K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.27M | 51.18M | 15.7M | 13.2M | 26.55M | 24.06M | 13.56M | 6.19M | 1.9M | 1.19M |
| Total Assets | 110.54M | 182.39M | 124.8M | 171.07M | 153.45M | 106.1M | 129.01M | 93.48M | 13.77M | 7.18M |
| Account Payables | 7.31M | 1.38M | 617K | 1.1M | 1.16M | 4.15M | 3.6M | 3.47M | 1.14M | 1.79M |
| Deferred Revenue | 368K | 27.11M | 10.37M | 1.86M | n/a | n/a | n/a | n/a | n/a | 512K |
| Short-Term Debt | 1.75M | 1.72M | 3.38M | 2.72M | 1.89M | 1.86M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 39.48M | 6.56M | 8.77M | 12.99M | 11.29M | 20.66M | 8.71M | 4.69M | 5.78M | 4.63M |
| Total Current Liabilities | 49.07M | 37.15M | 21.65M | 18.67M | 14.34M | 26.66M | 12.32M | 8.16M | 6.92M | 6.42M |
| Long-Term Debt | 2.55M | 3.83M | 4.96M | 5.97M | 6.89M | 4.62M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 12.79M | 23.69M | 96K | 49.35M | 177K | 249K | 833K | 365K | 493K | 1.01M |
| Total Long-Term Liabilities | 15.35M | 38.34M | 27.22M | 64.11M | 7.07M | 4.87M | 833K | 365K | 493K | 1.01M |
| Total Liabilities | 64.42M | 75.5M | 48.87M | 82.78M | 21.41M | 31.53M | 13.15M | 8.52M | 7.41M | 7.43M |
| Total Debt | 4.3M | 5.54M | 6.65M | 7.33M | 7.84M | 5.54M | n/a | n/a | n/a | n/a |
| Common Stock | 55K | 53K | 52K | 32K | 29K | 19K | 17K | 14K | 7.92M | n/a |
| Retained Earnings | -459.64M | -391.07M | -413.88M | -367.46M | -277.71M | -199.43M | -138.5M | -96.84M | -45.44M | -18.1M |
| Comprehensive Income | n/a | n/a | n/a | -2K | -7K | 16K | -28K | -643K | -290K | -11K |
| Shareholders Equity | 46.12M | 106.89M | 75.93M | 88.29M | 132.04M | 74.57M | 115.86M | 84.96M | 10.17M | 196K |
| Total Investments | n/a | 46.59M | n/a | 33.82M | 41.7M | 52.31M | 81.36M | 50K | 50K | 50K |